Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
Get 25% Off Sitewide on Cyber Monday Get 25% Off Sitewide on Cyber Monday

Comparing Ivermectin to Merck’s New Molnupiravir

  • October 17, 2021

Merck has a new antiviral drug, molnupiravir, that was being designed to treat influenza, but now is touted as a drug for COVID-19, even though its effectiveness for COVID is being questioned. As the FDA considers Merck’s request to bring it to market, retired nurse lecturer John Campbell, Ph.D., makes a critical comparison of the two in a YouTube video. To be upfront, Campbell says he is pro-vaccine and pro-antiviral. Ivermectin, he says, is one of the most-studied, repurposed drugs...
Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports